| # | Drug | Count |
|---|---|---|
| 0 | ELOTUZUMAB | 3 |
| 1 | LENALIDOMIDE | 2 |
| 2 | VALACYCLOVIR HYDROCHLORIDE | 2 |
| 3 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | 1 |
| 4 | ALLOPURINOL | 1 |
| 5 | CALCIUM | 1 |
| 6 | CARFILZOMIB | 1 |
| 7 | FLUTICASONE PROPIONATE | 1 |
| 8 | FUROSEMIDE | 1 |
| 9 | HYDROCHLOROTHIAZIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELOTUZUMAB | 3 | 0.0006 |
| 1 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 1 | 0.0001 |
| 2 | OFLOXACIN OTIC SOLUTION | 1 | 0.0001 |
| 3 | OFLOXACIN OTIC | 1 | 0.0001 |
| 4 | OFLOXACIN | 1 | 0.0001 |
| 5 | CARFILZOMIB | 1 | 0.0000 |
| 6 | VALACYCLOVIR HYDROCHLORIDE | 2 | 0.0000 |
| 7 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | 1 | 0.0000 |
| 8 | LATANOPROST | 1 | 0.0000 |
| 9 | LORATADINE TABLET | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 3 |
| 1 | Thalidomide Analog [EPC] | 3 |
| 2 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 3 | BCL-2 Inhibitor [EPC] | 1 |
| 4 | Calcium [EPC] | 1 |
| 5 | Endothelin Receptor Antagonist [EPC] | 1 |
| 6 | Factor Xa Inhibitor [EPC] | 1 |
| 7 | Insulin Analog [EPC] | 1 |
| 8 | Loop Diuretic [EPC] | 1 |
| 9 | Prostaglandin Analog [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 3 | 0.0006 |
| 1 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 2 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Prostaglandin Analog [EPC] | 1 | 0.0000 |
| 4 | Proteasome Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Calcium [EPC] | 1 | 0.0000 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Thalidomide Analog [EPC] | 3 | 0.0000 |
| 8 | Endothelin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Thiazide Diuretic [EPC] | 1 | 0.0000 |